Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Therapeutic Solutions International Inc TSOI

Therapeutic Solutions International, Inc. is focused on immune modulation for the treatment of several specific diseases. The Company is developing a range of immune-modulatory agents to target certain cancers, schizophrenia, suicidal ideation, and traumatic brain injury, and for daily health. The Company's flagship product, QuadraMune, is a multi-patented synergistic blend of pterostilbene... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (OTCPK:TSOI)

Therapeutic Solutions International Granted Patent on Commercially Available QuadraMune® Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients

Business Wire March 4, 2024

Therapeutic Solutions International Announces Landmark Finding Regarding Mechanism of Action of its JadiCell Stem Cell Product

Business Wire February 29, 2024

Therapeutic Solutions International Files Patent on "Facilitating Effects" of JadiCells on Gene Therapy Mediated Cell Differentiation

Business Wire February 26, 2024

Therapeutic Solutions International Files Lawsuit in San Diego Superior Court to Obtain Identities of Certain Individuals or Entities

Business Wire January 22, 2024

Therapeutic Solutions International Launches Adult Stem Cell Therapy Company Focused on Curing Epilepsy

Business Wire January 16, 2024

Therapeutic Solutions International Subsidiary Immunotherapy Company Res Nova Bio, Inc. Announces Positive Data on First Four Advanced Cancer Patients Treated with FloraStilbene(TM)

Business Wire January 3, 2024

Therapeutic Solutions International Announces Formation of ALS Biologics Inc to Commercialize Regenerative Technologies Related to Dreaded Motor Neuron Disease

Business Wire December 11, 2023

Therapeutic Solutions International and Campbell Neurosciences Publish on Nutritional Modulation of the Indolamine 2,3 Dioxygenase Pathway as a Non-Toxic Means of Addressing Depression

Business Wire November 27, 2023

Therapeutic Solutions International Collaborates on Peer-Reviewed Publication on Personalized Immunotherapy for Brain Cancer Using mRNA

Business Wire November 20, 2023

Opinion & Analysis (OTCPK:TSOI)

No current opinion is available.

Bullboard Posts (OTCPK:TSOI)

Therapeutic Solutions International Granted Patent on Commer

News; $TSOI Therapeutic Solutions International Granted Patent on Commercially Available QuadraMune&#xAE; Nutraceutical for...
whytestocks - March 4, 2024

Huge news!

Wow these guys never fail to impress. Todays news is further proof that these cellular medicines will be here to stay. From treating...
jefftrade11 - January 25, 2021

Interesting market here

I suppose I’ll go ahead and kick this board off. I’ve been taking neuenergy for the caffeine and pt since a hospitalization 3 years ago...
JuiceNewton - October 16, 2018